Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.56 |
| ▸ | ANPEP | P15144 | 5/20 | 0.46 |
| ▸ | RNPEP | Q9H4A4 | 2/20 | 0.46 |
| ▸ | DNPEP | Q9ULA0 | 1/20 | 0.46 |
| ▸ | SLC1A3 | P43003 | 1/20 | 0.43 |
| ▸ | SLC1A2 | P43004 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.41 |
| ▸ | MME | P08473 | 2/20 | 0.41 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.39 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.39 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.39 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.39 |
| ▸ | LARS1 | Q9P2J5 | 1/20 | 0.39 |
| ▸ | LAP3 | P28838 | 2/20 | 0.38 |
| ▸ | ERAP1 | Q9NZ08 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL76796 | 1.00 | SLC7A5 (0.56) | SLC7A5ANPEPRNPEPDNPEPSLC1A3 | |
| SCHEMBL700933 | 1.00 | SLC7A5 (0.56) | SLC7A5ANPEPRNPEPDNPEPSLC1A3 | |
| SCHEMBL29783468 | 1.00 | SLC7A5 (0.56) | SLC7A5ANPEPRNPEPDNPEPSLC1A3 | |
| Hydrochloric Acid SCHEMBL353346 | 0.98 | SLC7A5 (0.54) | SLC7A5ANPEPRNPEPDNPEPSLC1A3 | |
| Hydrochloric Acid SCHEMBL355415 | 0.98 | SLC7A5 (0.54) | SLC7A5ANPEPRNPEPDNPEPSLC1A3 | |
| Methyl Alcohol SCHEMBL28477033 | 0.98 | SLC7A5 (0.54) | SLC7A5ANPEPRNPEPDNPEPSLC1A3 | |
| Hydrochloric Acid SCHEMBL76795 | 0.98 | SLC7A5 (0.54) | SLC7A5ANPEPRNPEPDNPEPSLC1A3 | |
| Hydrochloric Acid SCHEMBL1532654 | 0.96 | SLC7A5 (0.52) | SLC7A5ANPEPRNPEPDNPEPSLC1A3 | |
| Alanine SCHEMBL7256054 | 0.92 | SLC7A5 (0.59) | SLC7A5ANPEPRNPEPDNPEPSLC1A3 | |
| Leucine SCHEMBL10382490 | 0.92 | SLC7A5 (0.72) | SLC7A5ANPEPRNPEPDNPEPSLC1A3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 879 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-122010765-A | Asymmetric alpha-amino acid or polypeptide derivative and preparation method and application thereof | 中国科学技术大学 | 2026-05-12 | — | — | CN | claimed |
| CN-119176846-A | Baohuoside I carbamate prodrug and salt, preparation and application thereof | 沈阳药科大学 | 2024-12-24 | — | — | CN | claimed |
| US-20240182642-A1 | GREEN SYNTHESIS OF AMINO ACID BASED POLY(ESTER UREA)S | MASSACHUSETTS INSTITUTE OF TECHNOLOGY | 2024-06-06 | — | — | US | claimed |
| CN-112585142-B | Novel antimalarial compounds, method for the production thereof and use thereof for the resistance of malaria | 科学与工业研究会 | 2024-01-19 | — | — | CN | claimed |
| CN-112280011-B | Preparation method of low-melting-index poly (butylene succinate) | 康辉新材料科技有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-112390940-B | Catalyst for polyester synthesis | 康辉新材料科技有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-112266471-B | Preparation method of polybutylene adipate-terephthalate | 康辉新材料科技有限公司 | 2022-08-05 | — | — | CN | claimed |
| CN-113999163-A | Synthetic cannabinoid hapten compounds, methods of making and uses thereof | 公安部第三研究所 | 2022-02-01 | — | — | CN | claimed |
| CN-109824655-B | Andrographolide compound and preparation method and application thereof | 沈阳药科大学 | 2021-09-24 | — | — | CN | claimed |
| CN-112280012-B | Preparation method of poly (butylene succinate) | 康辉新材料科技有限公司 | 2021-09-07 | — | — | CN | claimed |
| US-20030022895-A1 | 2-Amino-benzoxazinones for the treatment of viral infections | G.D. SEARLE & CO. | 2003-01-30 | — | — | US | claimed |
| CN-1070480-C | 2-amino-benzoxanones for the treatment of viral infections | SEARLE & CO (US) | 2001-09-05 | — | — | CN | claimed |
| EP-1122245-A2 | 2-Amino-benzoxazinones for the treatment of viral infections | G.D. Searle & Co. (US) | 2001-08-08 | — | — | EP | claimed |
| EP-0828721-A1 | 2-AMINO-BENZOXAZINONES FOR THE TREATMENT OF VIRAL INFECTIONS | G.D. SEARLE & CO. (US) | 1998-03-18 | — | — | EP | claimed |
| WO-1996037485-A1 | 2-AMINO-BENZOXAZINONES FOR THE TREATMENT OF VIRAL INFECTIONS | G.D. SEARLE & CO. (US) | 1996-11-28 | — | — | WO | claimed |
| EP-0483237-B1 | PROTECTION OF NK CELL CYTOLYTIC ACTIVITY IN PBMC | TERUMO CORP (JP) | 1994-09-28 | — | — | EP | claimed |
| US-5198334-A | Ester of Amino Acid or Dipeptide; Benzamidine, Phenylalaninol, Leucinol | TERUMO CORPORATION (JP) | 1993-03-30 | — | — | US | claimed |
| EP-0483237-A1 | PROTECTION OF NK CELL CYTOLYTIC ACTIVITY IN PBMC. | DU PONT (US) | 1992-05-06 | — | — | EP | claimed |
| WO-1991001370-A1 | PROTECTION OF NK CELL CYTOLYTIC ACTIVITY IN PBMC | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1991-02-07 | — | — | WO | claimed |
| US-4443475-A | ANTIARRHYTHMIA AGENTS, ANTIDEPRESSANTS | CAVAZZA CLAUDIO (IT) | 1984-04-17 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030022895-A1 | 2-Amino-benzoxazinones for the treatment of viral infections | IFNAR1, IL4I1, HAX1 | SLC7A5 1169/4885ANPEP 831/4885RNPEP 232/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.